[Serum resistin concentration and insulin resistance in obese children]

Ge-li Liu1, Xiao-hui Fu, Li-hong Jiang

  • 1Department of Pediatrics, General Hospital of Tianjin Medical University, Tianjin 300052, China.

Insights

Obese children have higher resistin levels, which correlate with obesity and fat distribution. This suggests resistin may play a role in developing insulin resistance and hyperinsulinemia in this population.

Area of Science:

  • Endocrinology
  • Pediatrics
  • Metabolic Syndrome

Background:

  • Obesity is a significant risk factor for insulin resistance and type 2 diabetes.
  • Adipocytes secrete factors like resistin that regulate energy balance.
  • Resistin's role in pediatric obesity and metabolic dysfunction requires further investigation.

Purpose of the Study:

  • To investigate the correlation between serum resistin levels and anthropometric/metabolic parameters in obese children.
  • To explore the association of resistin with hyperinsulinemia and insulin resistance in this cohort.

Main Methods:

  • Serum resistin concentrations were measured using ELISA in 34 obese children and 31 normal-weight controls.
  • Anthropometric data, fasting glucose, insulin, HOMA-R (insulin resistance), and HOMA-beta (beta-cell function) were assessed.
  • Correlation and multiple linear regression analyses were performed.

Main Results:

  • Obese children exhibited significantly higher serum resistin concentrations compared to normal subjects (P < 0.05).
  • Resistin positively correlated with BMI, body fat percentage, waist-hip ratio, fasting glucose, fasting insulin, and HOMA-R (P < 0.01).
  • Multiple regression analysis identified HOMA-R as the sole significant predictor of resistin levels (R² = 0.105, P < 0.01).

Conclusions:

  • Elevated serum resistin levels are observed in obese children.
  • Resistin concentrations are linked to the degree of obesity and fat distribution.
  • Resistin is implicated in the pathogenesis of hyperinsulinemia and insulin resistance in obese children.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...